Nurix Therapeutics, Inc. NRIX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s shares (diluted)?
- Nurix Therapeutics, Inc. (NRIX) reported shares (diluted) of 110.1M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Nurix Therapeutics, Inc.'s shares (diluted) increased by 31.7% year-over-year, from 83.6M to 110.1M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s shares (diluted) has grown at a 18.8% compound annual growth rate (CAGR), from 169.9M to 338.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.